Castle Biosciences will present TissueCypher Barrett’s Esophagus test data at DDW 2025, emphasizing risk stratification and personalized patient management. Castle Biosciences, Inc. will present new ...

Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and ...

My best friend texted me, responding to a photo I’d sent her from the doctor’s office as I waited to get a blood test (“Hospital gown chic!” I wrote). It wasn’t the first time I’d texted her while ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received assay ...

Scientists from the Barts Cancer Institute and the Francis Crick Institute have demonstrated that a genetic flaw that has long been thought to cause esophageal cancer may actually protect against the ...

Radio-frequency electrodes, balloon catheters, and a breakthrough sizing technology enable the Halo 360 system to ablate diseased eshophageal tissue associated with a precancerous condition. Whether ...